Intellia Therapeutics
NTLA
NTLA
Buy
Hold
Sell
12 Wall Street Analysts provided 1 year price targets over the past 3 months
| Analyst & Firm | Rating | Price Target |
Upside Downside | Date |
|---|---|---|---|---|
Wolfe Research
Andy Chen
100%
1-yr NTLA
win rate
| 12 Nov ‘25 18 days ago | |||
Jones Trading
Debanjana Chatterjee
| 11 Nov ‘25 18 days ago | |||
Evercore ISI Group
Jonathan Miller
| 11 Nov ‘25 19 days ago | |||
Truist Securities
Joon Lee
50%
1-yr NTLA
win rate
| 10 Nov ‘25 19 days ago | |||
HC Wainwright & Co
Mitchell Kapoor
44%
1-yr NTLA
win rate
| 10 Nov ‘25 19 days ago | |||
Chardan Capital
Geulah Livshits
40%
1-yr NTLA
win rate
| 7 Nov ‘25 22 days ago | |||
RBC Capital
Luca Issi
100%
1-yr NTLA
win rate
| 7 Nov ‘25 22 days ago | |||
Wells Fargo
Yanan Zhu
67%
1-yr NTLA
win rate
| 7 Nov ‘25 22 days ago | |||
Barclays
Gena Wang
33%
1-yr NTLA
win rate
| 7 Nov ‘25 22 days ago | |||
Wedbush
David Nierengarten
| 7 Nov ‘25 22 days ago | |||
Citizens
Silvan Tuerkcan
0%
1-yr NTLA
win rate
| 7 Nov ‘25 22 days ago | |||
JP Morgan
Brian Cheng
100%
1-yr NTLA
win rate
| 7 Nov ‘25 22 days ago | |||
Bernstein
William Pickering
| 28 Oct ‘25 1 month ago | |||
BofA Securities
Greg Harrison
0%
1-yr NTLA
win rate
| 27 Oct ‘25 1 month ago |